AKT2 CLIA Kit

Produktnummer ABIN6201180

Das Human AKT2 ELISA Kit (ABIN6201180) ist ein Chemiluminescent ELISA Kit zur Detektion von Human AKT2.

Kurzübersicht für AKT2 CLIA Kit (ABIN6201180)

Target: AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))

Reaktivität: Human

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.312 ng/mL - 20 ng/mL

Applikation: ELISA

Proben: Cell Lysate, Tissue Homogenate

Produktdetails AKT2 CLIA Kit

Untere Nachweisgrenze: 0.312 ng/mL

Verwendungszweck: Human Protein Kinase B beta (PKBb) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates, cell lysates and other biological fluids.

Analytische Methode: Quantitative

Sensitivität: < 0.124 ng/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Antigendetails

Target: AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))

Andere Bezeichnung: Protein Kinase B beta (PKBb)

Pathways: PI3K-Akt Signalweg, RTK Signalweg, AMPK Signaling, TLR Signalweg, Cellular Glucan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Hepatitis C, VEGF Signaling